Acute decompensated heart failure update. - Wikidata - wikimedia - TriplyDB

Acute decompensated heart failure update.

Acute decompensated heart failure update.

http://www.wikidata.org/entity/Q35139964

about

Trends in health care expenditure in U.S. adults with diabetes: 2002-2011.Advances in chemical pharmacotherapy for managing acute decompensated heart failure.New Medications in the Treatment of Acute Decompensated Heart Failure.

P2860

Q36087267-EC9F61B4-C642-47B9-8CF7-99DAEDD2DA9B Q39158670-6048EFED-0EE7-4CCE-99FA-4C57AE1BE8A3 Q52629414-E51BC9EC-686B-4084-88F2-5CA5AC9EF714

P2860

Acute decompensated heart failure update.

http://www.wikidata.org/entity/Q35139964

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Acute decompensated heart failure update.

@ast

Acute decompensated heart failure update.

@en

type

label

Acute decompensated heart failure update.

@ast

Acute decompensated heart failure update.

@en

prefLabel

Acute decompensated heart failure update.

@ast

Acute decompensated heart failure update.

@en

P1433

Q35139964-7AA20C06-5AC5-430F-AFC8-9E276B4B4891

P1476

Q35139964-6A034521-0A54-43A2-A557-DD92B41103FB

P2093

Q35139964-5484E3B4-8DB3-46DF-9190-6B1595940888

Q35139964-5860CC16-A47A-410E-83D9-E97647DDA8FB

Q35139964-C6ECF44F-BD96-44DF-AD02-23F194DC24B5

P275

Q35139964-7858133D-0D13-49FE-8A56-A320784CB64D

P2860

Q35139964-030DE1A2-5E35-4112-B86A-FD574819A852

Q35139964-0CE9E72E-C39B-4F7A-8E4F-B3FD584E09C6

Q35139964-11ED799A-DEFC-4AD6-805B-791441E6F35D

Q35139964-1A535339-2D32-4D3A-98D1-081F422A29F9

Q35139964-1A56B35D-51F8-402F-97B8-0F38CE0B36CA

Q35139964-1D7BE6BF-70B5-4E20-ADE0-E4340AE99A37

Q35139964-27447047-D1BB-4A19-9755-A1A993164B34

Q35139964-364F5587-AC87-4D0C-AD92-AD5737D4C504

Q35139964-3E840E85-B4A2-4023-9DFA-9D8E44D5E0E5

Q35139964-4417F1D1-68D8-4F6B-8736-F5ABA5AE735D

P304

Q35139964-D7CAE6A3-74B6-49A1-AE04-CF3EBB8294CF

P31

Q35139964-6D3B870C-72E2-45EB-8C00-09E06B7C44F6

Q35139964-A2DD333A-EFBA-40ED-A654-1DC3EE28C9F0

P356

Q35139964-282E981C-D3FF-458D-8D14-D9D5E803D489

P433

Q35139964-9DDD449A-FD1A-4A43-BA12-76D7947FC2A2

P478

Q35139964-ABF3278A-15A0-43A5-BB06-0900DFDF3F9D

P50

Q35139964-9FF5C507-8BCA-45B6-BD81-FE192DB1BF00

P5008

Q35139964-5F471316-989E-45E2-B769-B8805202C428

P577

Q35139964-C169BA21-42A8-4EA7-BE2E-C9535AC9612C

P698

Q35139964-D96B885E-CBDF-4439-BEAC-375DFB5F268E

P921

Q35139964-E2AAB492-7365-4FB4-A633-6FDCE3AEDD46

P932

Q35139964-4D414737-BB56-4160-B41E-63B21B9FC29A

P356

1573403X09666131117174414

P1433

Current cardiology reviews

P1476

Acute decompensated heart failure update.

@en

P2093

Jo E Rodgers

http://www.w3.org/2001/XMLSchema#string

John R Teerlink

http://www.w3.org/2001/XMLSchema#string

Khalid Alburikan

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial 3.0 Unported

P2860

2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Effect of nesiritide in patients with acute decompensated heart failure

Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis

Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial.

Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group.

HFSA 2010 Comprehensive Heart Failure Practice Guideline.

Dose-dependent augmentation of cardiac systolic function with the selective cardiac myosin activator, omecamtiv mecarbil: a first-in-man study.

The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial.

Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial.

Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure.

P304

53-62

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/1573403X09666131117174414

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

P5008

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24251454

http://www.w3.org/2001/XMLSchema#string

P921

P932

4347210

http://www.w3.org/2001/XMLSchema#string